Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00462059 · ClinicalTrials.gov registry record · NA

Assessment of a Medication Reconciliation Program on Transitional Care

A NA study of Hospitalization, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT00462059 is a NA study of Hospitalization that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants, below the 487-participant average among 3 other Hospitalization trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00462059, a NA study of Hospitalization, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess and compare the effectiveness of the Kaiser Permanente Colorado's (KPCO) Call Center's Medication Reconciliation Program and standard care in regards to their impacts on emergency department (ED) and urgent care visits, inpatient rehospitalizations, and adherence to preferred, formulary medications.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment

Study Locations (1)

Colorado

  • Kaiser-Permanente Colorado Region, Clinical Pharmacy Dept. - Aurora

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2005-06
Est. Completion 2007-03
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT00462059

The ClinicalTrials.gov registry entry for NCT00462059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 487-participant average among 3 other Hospitalization trials with a reported enrollment target (59% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hospitalization appearing as the primary indexed condition, and to 1 intervention - of which Treatment is the first listed.

NCT00462059 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00462059 about?

NCT00462059 is a clinical study titled "Assessment of a Medication Reconciliation Program on Transitional Care". The purpose of this study is to assess and compare the effectiveness of the Kaiser Permanente Colorado's (KPCO) Call Center's Medication Reconciliation Program and standard care in regards to their impacts on emergency department (ED) and urgent care visits, inpatient rehospitalizations, and adheren...

What is the current status of trial NCT00462059?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2005-06. Estimated completion is 2007-03.

What conditions does trial NCT00462059 study?

This clinical trial studies the following conditions: Hospitalization.

What interventions are being tested in trial NCT00462059?

The interventions under investigation include: Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00462059?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00462059 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hospitalization

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.